Evidation
11 Case Studies
A Evidation Case Study
Sanofi sought to understand the potential differences in health impairment across individuals with various respiratory conditions and demographic subgroups to identify unrecognized disease burden related to Type 2 inflammation.
Evidation addressed this by leveraging its virtual cohort of nearly 4 million individuals to connect with participants living with asthma, COPD, and/or nasal polyps. These participants completed a digitally administered St. George’s Respiratory Questionnaire (SGRQ). Evidation's analysis revealed a disproportionate impact on females and those with COPD, with findings showing these groups experienced significantly higher impairment scores. This real-world, digitally-captured insight aids in the development of improved management strategies for these patient subgroups.